European public biotech companies - key figures 2012-2016
The statistic depicts key figures on European public biotech companies from 2012 to 2016. In 2016, revenues of European public biotech companies amounted to some 27 billion U.S. dollars. In the same year, R&D spending stood at nearly seven billion dollars.